Requesting conflicts of interest declarations from the European Medicines Agency: 3-year follow-up status.

ABSTRACT:

Aims

We have previously described the European Medicines Agency's (EMA) and the US Food and Drug Administration's guidelines, each for a specific psychiatric indication, on how to design pivotal drug trials used in new drug applications. Here, we report on our efforts over 3 years to retrieve conflicts of interest declarations from EMA. We wanted to assess potential internal industry influence judged as the proportion of guideline committee members with industry conflicts of interest.

Methods

We submitted Freedom of Information requests in February 2020 to access EMA's lists of committee members (and their declared conflicts of interest) involved in drafting the 13 'Clinical efficacy and safety' guidelines available on EMA's website pertaining to psychiatric indications. In

SUBMITTER: Boesen K 

PROVIDER: S-EPMC11022247 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature